Imagene to Participate in the Jefferies Healthcare Conference on June 8
- Written by PR Newswire
SAN DIEGO, SHANGHAI and SYDNEY, May 30, 2023 /PRNewswire/ -- Inmagene Biopharmaceuticals ("Inmagene"), a global clinical-stage biotechnology company focused on developing novel therapeutics for immunology-related diseases, today announced that management has been invited to participate in the Jefferies Healthcare Conference, which will be...
Read more: Imagene to Participate in the Jefferies Healthcare Conference on June 8














